Piclozotan

Piclozotan

Systematic (IUPAC) name
3-chloro-4-[4-[4-(2-pyridinyl)-1,2,3,6-tetrahydropyridin-1-yl]butyl]-1,4-benzoxazepin-5(4H)-one
Clinical data
Legal status	Uncontrolled
Identifiers
CAS Number	182415-09-4 Y
PubChem	CID: 9801640
ChemSpider	7977402 N
UNII	FQE44HS7AH Y
Chemical data
Formula	C23H24ClN3O2
Molecular mass	409.909 g/mol
SMILES C1CN(CC=C1C2=CC=CC=N2)CCCCN3C(=COC4=CC=CC=C4C3=O)Cl
InChI InChI=1S/C23H24ClN3O2/c24-22-17-29-21-9-2-1-7-19(21)23(28)27(22)14-6-5-13-26-15-10-18(11-16-26)20-8-3-4-12-25-20/h1-4,7-10,12,17H,5-6,11,13-16H2 N Key:URMTUEWUIGOJBW-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Piclozotan (SUN-N4057) is a selective 5-HT_1A receptor partial agonist, which has neuroprotective effects in animal studies. It has been through early clinical trials in humans for treatment of acute stroke, but results have not yet been announced.

See also

• Repinotan
• Robalzotan